Sunder Biomedical Tech Co Ltd

Sunder Biomedical Tech Co Ltd has a debt-to-equity ratio of 0.51, indicating a moderate level of leverage. The company's liquidity position is characterized by a current ratio of 1.32, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -7.95 million TWD, which may indicate pressure on liquidity. The company's profitability is weak, with a return on equity of -2.15% and a return on assets of -1.28%. These figures are below the industry median for medical equipment and supplies firms, which typically report positive returns. The negative operating income of -18.33 million TWD and net income of -16.26 million TWD further underscore the company's current financial challenges. Sunder Biomedical Tech Co Ltd's revenue is primarily derived from the sale of medical consumables and related services. The company's geographic exposure is concentrated in Taiwan, with no significant international revenue disclosed. The company's product portfolio includes a wide range of medical supplies, but there is no indication of diversification across multiple business segments. The company's growth trajectory is uncertain, with no specific revenue growth projections provided. The negative operating and net income figures suggest that the company is not currently generating profits, which could impact its ability to invest in growth initiatives. The capital expenditure of -78.45 million TWD indicates that the company is investing in its operations, but the negative free cash flow suggests that these investments are not yet generating positive returns. The risk assessment for Sunder Biomedical Tech Co Ltd indicates a medium level of liquidity risk and a low level of dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to meet short-term obligations. The company's capital structure includes long-term debt of 388.66 million TWD, which may require refinancing in the future. There are no recent events or filings disclosed that would significantly impact the company's operations or financial position. The company's financial performance and risk profile suggest that it is currently facing challenges that may require strategic adjustments to improve profitability and liquidity.